ID: ALA5277232

Max Phase: Preclinical

Molecular Formula: C5H12NO4P

Molecular Weight: 181.13

Associated Items:

Representations

Canonical SMILES:  CC(=O)NCCCP(=O)(O)O

Standard InChI:  InChI=1S/C5H12NO4P/c1-5(7)6-3-2-4-11(8,9)10/h2-4H2,1H3,(H,6,7)(H2,8,9,10)

Standard InChI Key:  MFEBGTGDWTZQCJ-UHFFFAOYSA-N

Associated Targets(non-human)

1-deoxyxylulose-5-phosphate reductoisomerase 147 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 181.13Molecular Weight (Monoisotopic): 181.0504AlogP: -0.31#Rotatable Bonds: 4
Polar Surface Area: 86.63Molecular Species: ACIDHBA: 2HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.81CX Basic pKa: CX LogP: -2.03CX LogD: -4.39
Aromatic Rings: 0Heavy Atoms: 11QED Weighted: 0.41Np Likeness Score: -0.02

References

1. Kesharwani S, Sundriyal S..  (2021)  Non-hydroxamate inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): A critical review and future perspective.,  213  [PMID:33303239] [10.1016/j.ejmech.2020.113055]

Source